TY  - GEN
AU  - Aro,J
AU  - Ruutu,M
AU  - Juusela,H
AU  - Hansson,E
AU  - Permi,J
TI  - Polyestradiol phosphate (160 mg/month) or LHRH analog (buserelin depot) in the treatment of locally advanced or metastasized prostatic cancer. The Finnprostate Group
SN  - 0355-9874
PY  - 1994///0224
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Aged
KW  - Buserelin
KW  - administration & dosage
KW  - Cardiovascular Diseases
KW  - chemically induced
KW  - Estradiol
KW  - Estradiol Congeners
KW  - Finland
KW  - epidemiology
KW  - Humans
KW  - Male
KW  - Prospective Studies
KW  - Prostatic Neoplasms
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
ER  -